参考文献/References:
[1] Wink DA, Mitchell JB. Chemical biology of NO:Insights into regulatory, cytotoxic, and cytoprotective mechanisms of NO[J]. Free Radic Biol Med, 1998, 25:434-456.
[2] Moncada S, Higgs A, Furchgott RF. Ⅹ Ⅳ. International union of pharmacology nomenclature in nitric oxide research[J]. Pharmacol Rev, 1997, 49:137-142.[3] Xia Y, Tsai AL, Berka V, et al. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulindependent and tetrahydrobiopterin regulatory process[J]. J Biol Chem, 1998, 273:25804-25808.
[4] Chou TC, Li CY, Yen M H, et al. Antiplatelet effect of amlodipine:a possible mechanism through a nitric oxide-mediated process[J]. Biochem Pharmacol, 1999, 58:1657-1663.
[5] Nose M, Uzawa A, Nomura M, et al. Control of endotoxin shock by the dried preparation of low virulent streptococcus pyogenes OK-432[J]. Cell Immunol, 1998, 188:97-104.
[6] Calza L, Giardino L, Pozza M, et al. Time-course changes of nerve growth factor, corticotropin-releasing hormone and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis[J]. Proc Natl Acad Sci USA, 1997, 94:3368-3373.
[7] Vodovotz Y, Chesler L, Chong H, et al. Regulation of transforming growth factor β by nitric oxide[J]. Cancer Res, 1999, 59:2142-2149.
[8] O’Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets[J]. Immunity, 1998, 8:275-283.
[9] Bingisser RM, Tibrook PA, Holt PG, et al. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway[J]. J Immunol, 1998, 160:5729.
[10] Wink DA, Vodovotz Y, Laval J, et al. The multifaceted roles of nitric oxide in cancer[J]. Carcinogenesis, 1998, 19:711-721.
[11] Kim YM, Son K, Hong SJ, et al. Inhibition of protein synthesis by nitric oxide correlates with cytostatic activity:nitric oxide induces phosphorylation of initiation factor eIF-2 alpha[J]. Mol Med, 1998, 4:179.
[12] Ziche M, Morbidelli L, Chodhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis[J]. J Clin Invest, 1997, 99:2625-2634.
[13] Mitchell JB, DeGraff W, Kim S, et al. Redox generation of nitric oxide to radiosensitize hypoxic cells[J]. Int J Radiat Oncol Biol Phys, 1998, 42:795-798.
[14] McKinney LC, Aquilla EM, Coffin D, et al. Ionizing radiation potentiates the IFN-gamma and/or LPS in murine macrophage cell lines:role of TN F-alpha[J]. J Leukoc Biol, 1998, 64:459-466.
[15] Vodovotz Y, Coffin D, DeLuca AM, et al. Induction of nitric oxide production in infiltration leukocytes following in vivo irradiation of tumor-bearing mice[J]. Radiat Oncol Investig, 1999, 7:86-97.
[16] Clarencon D, Lestaevel P, Laval JD, et al. Valtametric measurement of blood nitric oxide in irradiated rats[J]. Int J Radiat Biol, 1999, 75:201-208.
相似文献/References:
[1]秦阳华,韩玲.辐射诱导旁效应研究进展[J].国际放射医学核医学杂志,2004,28(5):234.
QIN Yang-hua,HAN Ling.Progress of radiation-induced bystander effect[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):234.
[2]董正川,段玉清,樊赛军,等.新型辐射增敏药RRx-001[J].国际放射医学核医学杂志,2017,41(3):214.[doi:10.3760/cma.j.issn.1673-4114.2017.03.011]
Dong Zhengchuan,Duan YuQing,Fan Saijun,et al.A novel radiosensitizer RRx-001[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(4):214.[doi:10.3760/cma.j.issn.1673-4114.2017.03.011]